Hedge fund K2 acquires shares in Tribute Pharmaceuticals
K2 Principal Fund LP, an affiliate of Canadian hedge fund manager K2 & Associates Investment Management, has bought 9.2 million common shares and 4.7 million common share purchase warrants of Tribute Pharmaceuticals Canada Inc. Based in Milton, Ontario, Tribute is a specialty pharmaceutical company with a focus on the acquisition, licensing, development and promotion of healthcare products. As a result, K2 will own up to 14.05 percent of the company's issued and outstanding common shares. K2 has its headquarters in Toronto.
16 July 2014•1 min read
